Insights

Manufacturers

Case Study: Launching a new molecule for a rare disease

Manufacturers

Case Study: A proven approach for an emerging specialty pharma company

Manufacturers

Case Study: A flexible solution for launching a new molecule in oncology

Manufacturers

The value of Real-World Evidence in Canadian drug commercialization: Part 2

Manufacturers

Webinar: 2020 pan-Canadian Oncology Drug Review (pCODR) Updates

Manufacturers

Webinar: The Caregiver and Patient Support Programme

Manufacturers

Webinar: Utilizing Real World Evidence Across the Product Life Cycle

Manufacturers

Market Access: Negotiations

Manufacturers

Market Access: Reimbursement

Manufacturers

Market Access: Pricing

Manufacturers

Time-to-treatment initiation (TTI) in community infusion clinics - decreasing wait times for Canadian oncology patients

Manufacturers

Regulatory Services: Submission Filing

Manufacturers

Regulatory Services: Submission and Product Lifecycle Considerations

Manufacturers

Regulatory Services: How are products approved?

Manufacturers

Regulatory Services: Navigating Clinical Trial applications

Manufacturers

Commercializing in Canada: Quality Assurance and GMP Services

Manufacturers

Commercializing in Canada: Regulatory Publishing and Submissions

Manufacturers

Webinar: Health Canada’s Regulatory and Quality approach to addressing COVID-19 challenges

Manufacturers

3PL & Importation: Supporting your product commercialization through Importation

Manufacturers

3PL & Importation: Cost savings through Innomar's scalable supply chain solutions.

Manufacturers

3PL & Importation: Quality-assured, temperature-controlled and secure GMP-compliant facility.

Manufacturers

Why Canada: Leveraging our partnerships and relationships to assist in your launch strategy.

Manufacturers

Why Canada: How we help Pharmaceutical Manufacturers commercialize their products in Canada.

Manufacturers

Why Canada: Is Canada an attractive market for global pharmaceutical manufacturers?

Manufacturers

InnomarLive 2019: Commercializing in Canada

Manufacturers

Insight Series: The Value of Real-World Evidence in Canadian Drug Commercialization – Part 1

InnomarLive Summary: Healthcare Innovation

Manufacturers

Insight Series: Value of Patient Support Programs for Specialty Medications in Canada

Infographic: The Route to Market Access in Canada

Infographic: The Road to Commercialization in Canada

Insight Series: Biosimilars in Canada

Drug Reimbursement in Canada

Improved Health Outcomes in Patients Receiving Health Case Management

Understanding the Journey of a Person with a Rare Disease

Specialty pharmacies enhance patient outcomes [Pharmacy Practice Plus]

Case Study: Patient-centric Care in Rare Disease

Future of Patient Support Programs in Canada

Case Study: Optimizing a Patient Support Program to Improve Therapy Adherence

Case Study: Discovering New Opportunities for Growth in a Niche Market

Case Study: Leveraging Physician Relationships to Co-create Patient Support

Support Programs Designed to Assist Patients and Their Families

Big Wins in Record Time for Gaining Market Access with Phase II Data

Nurse-led Health Case Management